Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 1
2019 pubmed 20 citations

Association of Kiss1 and GPR54 Gene Polymorphisms with Polycystic Ovary Syndrome among Sri Lankan Women.

Branavan. Umayal U; Muneeswaran. Kajan K; Wijesundera. W S S WSS; Senanayake. Anoma A; Chandrasekharan. N Vishvanath NV; Wijeyaratne. Chandrika N CN

Key Findings

  • Women with PCOS had higher serum kisspeptin and testosterone than controls.
  • Five SNPs in GPR54 and two SNPs in Kiss1 were identified, but none differed significantly between PCOS patients and healthy women.
  • A novel GPR54 variant (chr19:918686) showed a borderline link to kisspeptin levels (p=0.053).

Practical Outcomes

  • For biohackers, the study doesn’t provide new dosing or protocol advice. It suggests that tweaking kisspeptin levels alone is unlikely to treat PCOS, and genetic testing for these variants isn’t currently useful for most people.

Summary

Researchers looked at genetic variations in the kisspeptin system (Kiss1 and its receptor GPR54) in Sri Lankan women with polycystic ovary syndrome (PCOS). They found that women with PCOS have higher blood levels of kisspeptin and testosterone, but the specific gene variants they studied don’t seem to explain why. One new genetic change might slightly affect kisspeptin levels, but overall the genetics don’t appear to drive PCOS in this group.

Abstract

Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder affecting women of reproductive age. Its aetiology, though yet unclear, is presumed to have an oligogenic basis interacting with environmental factors. Kisspeptins are peptide products of Kiss1 gene that control the hypothalamic pituitary (HPG) axis by acting via G protein-coupled receptor known as GPR54. There is paucity of data on the role of Kiss1 and GPR54 gene in PCOS. We aimed to identify the polymorphisms in Kiss1 and GPR54 genes and explore their association with serum kisspeptin levels among Sri Lankan women with well-characterized PCOS. Consecutive women with PCOS manifesting from adolescence (n=55) and adult controls (n=110) were recruited. Serum kisspeptin and testosterone levels were determined by ELISA method. Whole gene sequencing was performed to identify the polymorphisms in Kiss1 and GPR54 genes. Serum kisspeptin and testosterone concentrations were significantly higher in women with PCOS than controls: kisspeptin 4.873nmol/L versus 4.127nmol/L; testosterone 4.713nmol/L versus 3.415 nmol/L, p<0.05. Sequencing the GPR54 gene revealed 5 single nucleotide polymorphisms (SNPs), rs10407968, rs1250729403, rs350131, chr19:918686, and chr19:918735, with two novel SNPs (chr19:918686 and chr19:918735), while sequencing the Kiss1 gene revealed 2 SNPs, rs5780218 and rs4889. All identified SNPs showed no significant difference in frequency between patients and controls. GPR54 gene rs350131 polymorphism (G/T) was detected more frequently in our study population. The heterozygous allele (AG) of GPR54 gene novel polymorphism chr19:918686 showed a marginal association with serum kisspeptin levels (p=0.053). Genetic variations in GPR54 and Kiss1 genes are unlikely to be associated with PCOS among Sri Lankan women manifesting from adolescence. Meanwhile the heterozygous allele of chr19:918686 is probably associated with serum kisspeptin concentrations, which suggests a potential role in the aetiology of PCOS.

Study Information

Provider

pubmed

Year

2019

Date

2019-03-12T00:00:00.000Z

DOI

10.1155/2019/6235680

Citations

20

References

43